Suppr超能文献

白内障手术后非甾体类抗炎药的预防性使用与角膜溶解

Prophylactic Use of Nonsteroidal Anti-Inflammatory Drugs after Cataract Surgery and Corneal Melt.

作者信息

Ashena Zahra, Nanavaty Mayank A, Bardan Ahmed S, Thaker Riddhi, Bascaran Lucia

机构信息

Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.

Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, United Kingdom.

出版信息

J Curr Ophthalmol. 2022 Jan 6;33(4):485-491. doi: 10.4103/joco.joco_107_21. eCollection 2021 Oct-Dec.

Abstract

PURPOSE

To describe a case where prophylactic use of nonsteroidal anti-inflammatory drugs (NSAID) eye drops lead to recurrent corneal melt with loss of vision and a brief literature review.

METHODS

This is a case report of an 84-year-old diabetic female with chronic dry eye, operated by two different surgeons on each eye at different time intervals. She received topical NSAID prophylaxis after the second surgery only, which led to blindness due to recurrent corneal melt and chronic choroidal effusions. We also present a brief literature review.

RESULTS

This lady presented with corneal melt and perforation 5 days following the use of topical NSAIDs prophylaxis after a routine cataract surgery in the second eye. Unfortunately, all efforts to save her vision and eye were unsuccessful as she developed repeated complications in spite of corneal gluing, amniotic membrane, penetrating keratoplasty, and tarsorrhaphy. She also had chronic choroidal effusions. She ended up with an opaque cornea and a subtotal tarsorrhaphy, with no other option to improve her vision as she did not qualify for sedation or general anesthesia due to her poor systemic health.

CONCLUSION

Although it is a common practice for diabetic patients to have topical NSAIDs prophylaxis in combination with steroid eye drops to reduce the risk of cystoid macular edema after cataract surgery, the elderly diabetic patients with concomitant dry eyes should be considered high risk for corneal melt and should be closely monitored. This case highlights the rare but serious complication of topical NSAIDs prophylaxis in the vulnerable cornea, which warrants careful consideration.

摘要

目的

描述一例预防性使用非甾体类抗炎药(NSAID)眼药水导致复发性角膜溶解并丧失视力的病例,并进行简要的文献综述。

方法

这是一例84岁患有慢性干眼症的糖尿病女性病例报告,两只眼睛在不同时间由两位不同的外科医生进行手术。仅在第二次手术后她接受了局部NSAID预防治疗,这导致因复发性角膜溶解和慢性脉络膜积液而失明。我们还进行了简要的文献综述。

结果

这位女士在第二只眼睛进行常规白内障手术后使用局部NSAID预防治疗5天后出现角膜溶解和穿孔。不幸的是,尽管进行了角膜粘连、羊膜移植、穿透性角膜移植术和睑裂缝合术,但由于她出现了反复的并发症,所有挽救她视力和眼睛的努力均未成功。她还患有慢性脉络膜积液。最终她角膜混浊,睑裂缝合不完全,由于全身健康状况不佳,她不符合镇静或全身麻醉的条件,因此没有其他改善视力的选择。

结论

尽管糖尿病患者在白内障手术后联合使用局部NSAID预防治疗和类固醇眼药水以降低黄斑囊样水肿的风险是一种常见做法,但患有干眼症的老年糖尿病患者应被视为角膜溶解的高风险人群,需要密切监测。本病例突出了局部NSAID预防治疗在脆弱角膜中罕见但严重的并发症,这值得仔细考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8058/8772489/625dc098a515/JCO-33-485-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验